Early monitoring for detection of antituberculous drug-induced hepatotoxicity
The Korean Journal of Internal Medicine
;
: 65-72, 2016.
Artigo
em Inglês
| WPRIM
| ID: wpr-220501
ABSTRACT
BACKGROUND/AIMS:
We investigated the time of onset of antituberculous drug-induced hepatotoxicity (ADIH) and related characteristics.METHODS:
Adult patients (n = 1,031) treated with first-line antituberculous drugs between February 2009 and January 2013 were enrolled.RESULTS:
Of the 1,031 patients, 108 patients (10.5%) developed ADIH a mean of 39.6 +/- 43.7 days after treatment initiation. Twenty-eight patients (25.9%) developed ADIH within 7 days, 73 (67.6%) within 30 days, and the rest after 30 days. The 30-day group. In subgroup analysis, the 40 IU/L (odds ratio [OR], 2.995; 95% confidence interval [CI], 1.580 to 5.680; p = 0.001) and presence of anti-hepatitis C virus (OR, 4.204; 95% CI, 1.822 to 9.700, p = 0.001) were independent risk factors for development of ADIH.CONCLUSIONS:
Approximately 70% of the cases of ADIH occurred in the first month of antituberculous treatment, and were associated with continuation of the first-line drug regimen.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Aspartato Aminotransferases
/
Fatores de Tempo
/
Biomarcadores
/
Distribuição de Qui-Quadrado
/
Modelos Logísticos
/
Razão de Chances
/
Análise Multivariada
/
Valor Preditivo dos Testes
/
Estudos Retrospectivos
/
Fatores de Risco
Tipo de estudo:
Estudo diagnóstico
/
Estudo de etiologia
/
Estudo observacional
/
Estudo prognóstico
/
Fatores de risco
/
Estudo de rastreamento
Limite:
Adulto
/
Idoso
/
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
The Korean Journal of Internal Medicine
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS